Literature DB >> 19815637

Determinants and correlation of systemic and cervical concentrations of total IgA and IgG.

Mahboobeh Safaeian1, Troy Kemp, Roni T Falk, Ana Cecilia Rodriguez, Allan Hildesheim, Marcus Williams, Carolina Porras, Rolando Herrero, Ligia A Pinto.   

Abstract

We compared systemic and cervical total IgA and IgG during the menstrual cycle among 154 women who attended clinic visits at follicular/early, periovulatory/mid, and luteal/late phases of menstrual cycle. Paired serum and cervical secretions were tested at each visit for total IgA and IgG using ELISA. Geometric mean titers for systemic IgA and IgG were 1.92 and 8.25 mg/mL, respectively. There were no differences in titers by menstrual cycle phase, neither were they correlated to cervical titers (rho = 0.17 and 0.16, respectively). The lack of correlation between systemic and cervical total IgA and IgG suggests that systemic concentrations are not reflective of cervical levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19815637      PMCID: PMC2762345          DOI: 10.1158/1055-9965.EPI-09-0348

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  14 in total

1.  The strength of B cell immunity in female rhesus macaques is controlled by CD8+ T cells under the influence of ovarian steroid hormones.

Authors:  F X Lü; K Abel; Z Ma; T Rourke; D Lu; J Torten; M McChesney; C J Miller
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

2.  Characterization of immunoglobulins and cytokines in human cervical mucus: influence of exogenous and endogenous hormones.

Authors:  R D Franklin; W H Kutteh
Journal:  J Reprod Immunol       Date:  1999-03       Impact factor: 4.054

3.  Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial.

Authors:  Diane M Harper; Eduardo L Franco; Cosette M Wheeler; Anna-Barbara Moscicki; Barbara Romanowski; Cecilia M Roteli-Martins; David Jenkins; Anne Schuind; Sue Ann Costa Clemens; Gary Dubin
Journal:  Lancet       Date:  2006-04-15       Impact factor: 79.321

4.  Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women.

Authors:  Troy J Kemp; Alfonso García-Piñeres; Roni T Falk; Sylviane Poncelet; Francis Dessy; Sandra L Giannini; Ana Cecilia Rodriguez; Carolina Porras; Rolando Herrero; Allan Hildesheim; Ligia A Pinto
Journal:  Vaccine       Date:  2008-05-19       Impact factor: 3.641

5.  Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project.

Authors:  R Herrero; M H Schiffman; C Bratti; A Hildesheim; I Balmaceda; M E Sherman; M Greenberg; F Cárdenas; V Gómez; K Helgesen; J Morales; M Hutchinson; L Mango; M Alfaro; N W Potischman; S Wacholder; C Swanson; L A Brinton
Journal:  Rev Panam Salud Publica       Date:  1997-05

6.  Immunoglobulin (Ig) G, IgA, and IgA subclass antibodies against fertilization antigen-1 in cervical secretions and sera of women of infertile couples.

Authors:  A C Menge; R K Naz
Journal:  Fertil Steril       Date:  1993-10       Impact factor: 7.329

7.  Levels of interferon-gamma and tumor necrosis factor-alpha in sera and cervical mucus of fertile and infertile women: implication in infertility.

Authors:  R K Naz; A Butler; B R Witt; D Barad; A C Menge
Journal:  J Reprod Immunol       Date:  1995-07       Impact factor: 4.054

8.  Effects of ovarian steroids on immunoglobulin-secreting cell function in healthy women.

Authors:  Fabien X Lü; Zhongmin Ma; Susie Moser; Thomas G Evans; Christopher J Miller
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

9.  Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles.

Authors:  Denise Nardelli-Haefliger; Daniel Wirthner; John T Schiller; Douglas R Lowy; Allan Hildesheim; Françoise Ponci; Pierre De Grandi
Journal:  J Natl Cancer Inst       Date:  2003-08-06       Impact factor: 13.506

10.  Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.

Authors:  Jorma Paavonen; David Jenkins; F Xavier Bosch; Paulo Naud; Jorge Salmerón; Cosette M Wheeler; Song-Nan Chow; Dan L Apter; Henry C Kitchener; Xavier Castellsague; Newton S de Carvalho; S Rachel Skinner; Diane M Harper; James A Hedrick; Unnop Jaisamrarn; Genara Am Limson; Marc Dionne; Wim Quint; Bart Spiessens; Pascal Peeters; Frank Struyf; Susan L Wieting; Matti O Lehtinen; Gary Dubin
Journal:  Lancet       Date:  2007-06-30       Impact factor: 79.321

View more
  4 in total

1.  ZMapp Reinforces the Airway Mucosal Barrier Against Ebola Virus.

Authors:  Bing Yang; Alison Schaefer; Ying-Ying Wang; Justin McCallen; Phoebe Lee; Jay M Newby; Harendra Arora; Priya A Kumar; Larry Zeitlin; Kevin J Whaley; Scott A McKinley; William A Fischer; Dimple Harit; Samuel K Lai
Journal:  J Infect Dis       Date:  2018-08-14       Impact factor: 5.226

2.  Phase I randomised clinical trial of an HIV-1(CN54), clade C, trimeric envelope vaccine candidate delivered vaginally.

Authors:  David J Lewis; Carol A Fraser; Abdel N Mahmoud; Rebecca C Wiggins; Maria Woodrow; Alethea Cope; Chun Cai; Rafaela Giemza; Simon A Jeffs; Maria Manoussaka; Tom Cole; Martin P Cranage; Robin J Shattock; Charles J Lacey
Journal:  PLoS One       Date:  2011-09-30       Impact factor: 3.240

3.  Oral Immunoglobulin Levels are Not a Good Surrogate for Cervical Immunoglobulin Levels.

Authors:  Troy J Kemp; Mahboobeh Safaeian; Samantha Miner; Marcus C Williams; Ana Cecilia Rodriguez; Rolando Herrero; Allan Hildesheim; Ligia A Pinto
Journal:  Front Oncol       Date:  2012-06-25       Impact factor: 6.244

4.  Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS.

Authors:  Nirupama Putcha; Gabriel G Paul; Antoine Azar; Robert A Wise; Wanda K O'Neal; Mark T Dransfield; Prescott G Woodruff; Jeffrey L Curtis; Alejandro P Comellas; M Bradley Drummond; Allison A Lambert; Laura M Paulin; Ashraf Fawzy; Richard E Kanner; Robert Paine; MeiLan K Han; Fernando J Martinez; Russell P Bowler; R Graham Barr; Nadia N Hansel
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.